Vaccine distribution planned on UC campus
April 2, 2021
COVID-19 vaccine distribution planned for Ohio campuses
April 2, 2021
COVID-19 vaccine distribution planned for Ohio campuses
March 31, 2021
A new study reveals that an evidence-based treatment may help predict treatment outcomes for adolescents with anxiety disorders. University of Cincinnati researchers say this could determine medication effectiveness more quickly to help patients.
June 9, 2021
University of Cincinnati researchers found that while N95 masks are effective barriers against airborne diseases like COVID-19, poorly fitting masks can have substantial leaks around the face that reduce their effectiveness and increase the risk of infection.
June 9, 2021
Baseball season is back, and that means it’s time for Hoxworth Blood Center’s annual Cincinnati Reds blood drive!
May 24, 2021
Celebrate this year’s cicada invasion (or simply escape the hordes of buzzing, red-eyed locusts) by donating blood at Hoxworth Blood Center.
May 24, 2021
The University of Cincinnati College of Medicine awarded 176 medical degrees during Honors Day, Sunday, May 23 in Fifth Third Arena. UC President Neville Pinto, UC Board of Trustees Chair Ronald Brown and Dean Andrew Filak, MD, of the College of Medicine offered remarks. Farzaan Kassam, a fourth-year medical student, was this year's class speaker.
May 25, 2021
Kate Chard, PhD, explains how sports fans can actually get sick from watching sports and how to manage stressful situations.
May 26, 2021
A new study by the University of Cincinnati finds that fatal opiate overdoses are most prevalent in six states: Ohio, Pennsylvania, Kentucky, West Virginia, Indiana and Tennessee. Researchers identified 25 hot spots of fatal opioid overdoses nationwide using data from the Centers for Disease Control and Prevention. The study demonstrates how both widespread and localized the problem of substance use disorders can be.
May 28, 2021
UC's Kevin Li leads research on alternative treatments for eye diseases.
May 18, 2021
A team of scientists at the University of Cincinnati is developing a therapy that — when taken together — can improve existing melanoma treatments.